Heron Therapeutics HRTX
NASDAQ HRTX
$0.35 -0.01 (-2.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Heron Therapeutics (HRTX) Selling, General & Administrative (2010 - 2026)

Updated

Heron Therapeutics (HRTX) posted Selling, General & Administrative of $11.28 million for Q2 2026, down 22.1% from $14.47 million a year earlier and down 7.2% from the prior quarter.

Analysis

Heron Therapeutics (HRTX) Selling, General & Administrative (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Heron Therapeutics was $50.85 million, down 1.6% year-over-year; for FY2025, it was $54.61 million, up 2.3% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
  • In prior years, Heron Therapeutics' Selling, General & Administrative was $53.4 million in FY2024 (-18.8%), $65.78 million in FY2023 (+5.7%), $62.24 million in FY2022 (+55.0%) and $40.15 million in FY2021 (-4.9%).
  • The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative since Q3 2022.
  • On a year-over-year basis, Selling, General & Administrative increased in three of the last eight quarters, with an average decline of 6.5%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2022, with growth of 241.1%; the weakest was Q4 2023, with a decline of 57.2%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $12.15 million (Q1 2026), $13.45 million (Q4 2025) and $13.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Heron Therapeutics 66.45 Mn -123.12 Mn 26.09 Mn 11.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.28 Mn
Mar 31, 2026 12.15 Mn
Dec 31, 2025 13.45 Mn
Sep 30, 2025 13.98 Mn
Jun 30, 2025 14.47 Mn
Mar 31, 2025 12.70 Mn
Dec 31, 2024 12.15 Mn
Sep 30, 2024 12.37 Mn
Jun 30, 2024 13.91 Mn
Mar 31, 2024 14.97 Mn
Dec 31, 2023 14.44 Mn
Sep 30, 2023 15.91 Mn
Jun 30, 2023 19.59 Mn
Mar 31, 2023 15.83 Mn
Dec 31, 2022 33.73 Mn
Sep 30, 2022 9.80 Mn
Jun 30, 2022 9.18 Mn
Mar 31, 2022 9.53 Mn
Dec 31, 2021 9.89 Mn
Sep 30, 2021 9.79 Mn
API Access

Heron Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=HRTX&period=max&api_key=YOUR_API_KEY